Glynn RJ - Search Results

1

Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populations.

Wang SV, Gagne JJ, Glynn RJ, Schneeweiss S. Wang SV, et al. Among authors: glynn rj. Epidemiology. 2013 May;24(3):375-8. doi: 10.1097/EDE.0b013e31828ac9cb. Epidemiology. 2013. PMID: 23466528 Free PMC article.

2

Aspirin use and cognitive function in the elderly.

Stürmer T, Glynn RJ, Field TS, Taylor JO, Hennekens CH. Stürmer T, et al. Among authors: glynn rj. Am J Epidemiol. 1996 Apr 1;143(7):683-91. doi: 10.1093/oxfordjournals.aje.a008801. Am J Epidemiol. 1996. PMID: 8651230

3

Cancer occurrence in the elderly: agreement between three major data sources.

Stang A, Glynn RJ, Gann PH, Taylor JO, Hennekens CH. Stang A, et al. Among authors: glynn rj. Ann Epidemiol. 1999 Jan;9(1):60-7. doi: 10.1016/s1047-2797(98)00031-3. Ann Epidemiol. 1999. PMID: 9915610

4

Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly.

Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Glynn RJ, et al. Am J Epidemiol. 1999 Mar 15;149(6):541-9. doi: 10.1093/oxfordjournals.aje.a009850. Am J Epidemiol. 1999. PMID: 10084243

5

Paradoxical relations of drug treatment with mortality in older persons.

Glynn RJ, Knight EL, Levin R, Avorn J. Glynn RJ, et al. Epidemiology. 2001 Nov;12(6):682-9. doi: 10.1097/00001648-200111000-00017. Epidemiology. 2001. PMID: 11679797

6

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Schneeweiss S, et al. Among authors: glynn rj. Am J Epidemiol. 2001 Nov 1;154(9):854-64. doi: 10.1093/aje/154.9.854. Am J Epidemiol. 2001. PMID: 11682368

7

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB. Schneeweiss S, et al. Among authors: glynn rj. N Engl J Med. 2002 Mar 14;346(11):822-9. doi: 10.1056/NEJMsa003087. N Engl J Med. 2002. PMID: 11893794 Free article.

8

Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.

Schneeweiss S, Soumerai SB, Glynn RJ, Maclure M, Dormuth C, Walker AM. Schneeweiss S, et al. Among authors: glynn rj. CMAJ. 2002 Mar 19;166(6):737-45. CMAJ. 2002. PMID: 11944760 Free PMC article.

9

Clozapine use and risk of diabetes mellitus.

Wang PS, Glynn RJ, Ganz DA, Schneeweiss S, Levin R, Avorn J. Wang PS, et al. Among authors: glynn rj. J Clin Psychopharmacol. 2002 Jun;22(3):236-43. doi: 10.1097/00004714-200206000-00002. J Clin Psychopharmacol. 2002. PMID: 12006892

10

Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance.

Schneeweiss S, Maclure M, Soumerai SB, Walker AM, Glynn RJ. Schneeweiss S, et al. Among authors: glynn rj. J Clin Epidemiol. 2002 Aug;55(8):833-41. doi: 10.1016/s0895-4356(02)00437-7. J Clin Epidemiol. 2002. PMID: 12384199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

687 results

Search Page